Allergy Diagnostics and Therapeutics Market
Report ID: SQMIG35H2183
Report ID: SQMIG35H2183
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35H2183 |
Region:
Global |
Published Date: November, 2025
Pages:
219
|Tables:
90
|Figures:
76
Allergy Diagnostics and Therapeutics Market size was valued at USD 33.39 Billion in 2024 and is poised to grow from USD 36.33 Billion in 2025 to USD 71.33 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026–2033).
The global allergy diagnostics market is anticipated to experience significant growth during the forecast period due to several factors. Firstly, the escalating levels of environmental pollution on a global scale and the increased availability of healthcare insurance are expected to contribute to market expansion. Additionally, the high prevalence of allergic diseases, which imposes a substantial economic burden, and the increased investment by organizations in the field of Allergy Diagnostics are driving market growth.
Changing lifestyle patterns, such as the consumption of unhealthy and processed foods, along with rising pollution levels, are major factors fuelling the growth of the global Allergy Diagnostics market in the foreseeable future. Furthermore, there is a notable increase in food allergies, primarily attributed to individuals' lack of awareness about maintaining a healthy diet. This trend is expected to drive the demand for Allergy Diagnostics in the coming years. The integration of mobile health (mHealth) solutions in allergy diagnosis is another significant driver of market growth during the forecast period. Moreover, ongoing research and analysis on new treatment approaches and the adoption of advanced diagnostic strategies for allergies present key opportunities in the Allergy Diagnostics market. The advancement of technology offers substantial growth prospects in the Allergy Diagnostics market, particularly through the introduction of various types of blood tests aimed at mitigating further health complications. The rapidly changing lifestyle patterns and the increased consumption of processed foods, especially among the younger population, are expected to drive the growth of the global Allergy Diagnostics market in the coming years.
US Allergy Diagnostics and Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2026-2033
Global Market Size
USD 30.69 Billion
Largest Segment
Drug
Fastest Growth
Drug
Growth Rate
8.8% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Allergy Diagnostics and Therapeutics Market is segmented by type, allergen type, test type and region. Based on type, the market is segmented into diagnostics and therapeutics. Based on allergen type, the market is segmented into food, inhaled, drug and other allergens. Based on test type, the market is segmented into in vivo test and in vitro test. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
In the allergy diagnostics and therapeutics market, inhaled allergies accounted for the highest revenue share. This can be attributed to the escalating occurrences of respiratory allergies caused by the rise in air pollution and industrialization. The Allergy and Asthma Foundation of America estimates that seasonal allergic rhinitis was expected to affect around 81 million individuals in the United States.
The growing prevalence of allergic rhinitis presents promising growth opportunities for the market. Among the different segments, drug allergies are projected to exhibit the fastest compound annual growth rate (CAGR) in the foreseeable future. Drug allergies can lead to severe conditions such as Steven-Johnson syndrome and toxic epidermal necrolysis, particularly in children. Chemotherapy drugs, antiepileptic drugs, and sulfonamide drugs are among the most commonly associated agents with drug allergies.
The in vivo test segment held a substantial market share of 48.85% in the allergy diagnostics and therapeutics market in 2022. This can be attributed to the rising adoption of in vivo tests, which offer convenience, cost-effectiveness, and safety compared to other types of tests. The demand for efficient, rapid, and simple testing options has driven the growth of in vivo diagnostic tests. These tests assess the reactivity and susceptibility of dermal mast cells, providing insights into allergic sensitivity. Standardized allergenic extracts are used in these procedures to ensure reliability during skin examinations.
The in vitro tests segment is anticipated to witness significant growth with a notable compound annual growth rate (CAGR) over the forecast period. In vitro tests are employed to identify allergen-specific immunoglobulin E (IgE). A radio allergo sorbent screening is an in vitro method that detects allergen-specific antibodies of a new immunoglobulin class called IgND. The increasing prevalence of various allergic diseases among the population has heightened the demand for early detection and diagnosis of allergens, driving the need for efficient diagnostic tests or systems and propelling market growth.
To get detailed segments analysis, Request a Free Sample Report
The allergy diagnostics and therapeutics market in North America took the lead with a significant revenue. This can be attributed to several factors, including the increasing prevalence of allergies and favorable government initiatives in the region. North America is a developed region with a high level of healthcare expenditure. According to the Asthma and Allergy Foundation of America, the annual cost of nasal allergies in the region ranges between USD 3-4 billion. The presence of regulatory bodies in North American countries is expected to drive advancements in allergy drugs in the near future. These regulatory bodies play a crucial role in raising awareness among consumers about the importance of early diagnosis and therapeutics for allergies.
On the other hand, the Asia Pacific region is projected to exhibit the fastest compound annual growth rate over the forecast period. Within the Asia Pacific, notable markets include Japan, China, and India, which are expected to contribute to the regional market's growth. Key players in these countries are implementing various strategic initiatives to strengthen their dominance. Additionally, Glenmark launched its nasal spray Ryaltris, designed to treat moderate to severe allergic rhinitis, in India.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increased Prevalence and Heavy Economic Burden of Allergic Diseases
Rise in Access to Health Insurance
Challenges
Request Free Customization of this report to help us to meet your business objectives.
The global market for allergy diagnostics and therapeutics is highly competitive and characterized by the presence of several key players. These companies focus on strategic initiatives such as product launches, collaborations, partnerships, and mergers and acquisitions to maintain their market position and gain a competitive edge. They also emphasize research and development activities to introduce innovative solutions and stay ahead in the market. The market players strive to expand their geographical presence and strengthen their distribution networks to cater to a wider customer base. Additionally, they invest in marketing and promotional activities to increase product visibility and brand awareness. These players also actively participate in regulatory compliance and adhere to quality standards to ensure the safety and effectiveness of their products. Moreover, technological advancements play a crucial role in the competitive landscape of the allergy diagnostics and therapeutics market. Companies continuously innovate and develop advanced diagnostic tools and therapeutic solutions to meet the evolving needs of healthcare professionals and patients. The competitive landscape is further influenced by factors such as pricing strategies, reimbursement policies, and customer service. Companies aim to offer competitive pricing while maintaining product quality and profitability. They also focus on providing excellent customer service and support to enhance customer satisfaction and loyalty. Overall, the global allergy diagnostics and therapeutics market is marked by intense competition among key players, who strive to differentiate themselves through product innovation, market expansion, and customer-centric strategies.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global allergy diagnostics and therapeutics market analysis, the increasing prevalence of allergic diseases, technological advancements in diagnostics, and the growing focus on personalized medicine are the key growth drivers. The market is witnessing a shift towards at-home testing, driven by the demand for convenient and accessible allergy testing options. Furthermore, collaborations and partnerships among key players are fostering innovation and the development of advanced diagnostic tools and therapeutic solutions. The dominant region in the global allergy diagnostics and therapeutics market is North America, which accounted for a significant share in terms of revenue. Factors such as the rising incidence of allergies, favorable government initiatives, and high healthcare expenditure contribute to the region's market dominance. On the other hand, the Asia Pacific region is projected to exhibit the fastest growth during the forecast period. Countries like Japan, China, and India are notable markets driving regional growth. Key players in these countries are undertaking strategic initiatives to increase their market presence and cater to the growing demand for allergy diagnostics and therapeutics.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 33.39 Billion |
| Market size value in 2033 | USD 71.33 Billion |
| Growth Rate | 8.8% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Allergy Diagnostics and Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Allergy Diagnostics and Therapeutics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Allergy Diagnostics and Therapeutics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Allergy Diagnostics and Therapeutics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
